Close

Syngene and HiMedia partner to manufacture Covid-19 test kits in India

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

UK Life Sciences Sector Plan Eases Startup Regulations

How the UK Life Sciences Sector Plan Reduces Regulatory...

Biocon’s research arm Syngene has partnered with bioscience company HiMedia Laboratories to manufacture and distribute ELISA antibody test kits for Covid-19 in India.

Syngene’s anti-COV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) is considered to be a highly reliable test that detects the presence of SARS-COV-2 antibodies in blood samples. The test has the capacity to run multiple samples at once and deliver results in three hours.

Following the partnership, HiMedia will manufacture the kits at its facility in Mumbai and distribute it across India.

For developing the prototypes for CDSCO approval, Syngene will begin tech-transfer of the kits to HiMedia. The test was developed by Syngene at its research facility in Bengaluru.

Syngene International chief operating officer Dr Mahesh Bhalgat said: “At a time when the number of Covid-19 cases is increasing at an alarming rate across the country, there is an urgent need to make available reliable testing kits, using advanced technology to test patients and identify positive cases.

“To fill this gap, Syngene, with its expertise across diverse scientific domains, has developed an ELISA kit that allows higher throughput and generates faster results. We are happy to tie-up with HiMedia who will make the kits available at a large scale to significantly increase serological testing in India.”

HiMedia is expected to roll out the kits in two weeks after receiving the approval and market it under its brand name ELISafe 19.

HiMedia Laboratories Cell Culture and Immunology research and development (R&D) director Dr Vishal Warke said: “We are happy to partner with Syngene in manufacturing and distributing their ELISA kits. This partnership brings together our mutual expertise in research and manufacturing and will further strengthen our fight against the Covid-19 pandemic.”

Syngene previously collaborated with Pune-based molecular diagnostics company Mylab Discovery Solutions to provide raw materials for RT-PCR based Covid-19 test kits.

Latest stories

Related stories

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

UK Life Sciences Sector Plan Eases Startup Regulations

How the UK Life Sciences Sector Plan Reduces Regulatory...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back